Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects
Clinical trial NCT04441918 · UNKNOWN
Trial details
- NCT number
- NCT04441918
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-05
- Primary completion
- 2020-12-11
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.